Antigen-specific CD25-Foxp3-IFN- γhighCD4+ T cells restrain the development of experimental allergic encephalomyelitis by suppressing Th17

American Journal of Pathology

Volumn 176, Issue 6, 2010, Pages 2764-2775

  Wildbaum, Gizi ^a   Zohar, Yaniv ^a   Karin, Nathan ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; INTERLEUKIN 17;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE COURSE; FEMALE; MOUSE; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH17 CELL; ANIMAL; C57BL MOUSE; CELL SEPARATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FLOW CYTOMETRY; GENETICS; HELPER CELL; HUMAN; IMMUNOLOGY;

ANIMALS; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FAS LIGAND PROTEIN; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 77953210389     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090855     Document Type: Article

References (38)

1. Stromnes IM, Cerretti LM, Liggitt D, Harris RA, Goverman JM: Differential regulation of central nervous system autoimmunity by Th1 and Th17 cells. Nat Med 2008, 14:337-342
2. Kroenke MA, Carlson TJ, Andjelkovic AV, Segal BM: IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med 2008, 205:1535-1541
3. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Lucian L, To W, Kwan S, Churakova T, Zurawski S, Wiekowski M, Lira SA, Gorman D, Kastelein RA, Sedgwick JD: Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748
4. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240
5. + T cells to induce experimental autoimmune encephalomyelitis by a nonencephalitogenic myelin variant antigen. J Immunol 2008, 180:4451-4457
6. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1069-1070
7. Steinman L: A brief history of Th17, the first major revision in the Th1/Th2 hypothesis of T cell-mediated tissue damage. Nat Med 2007, 13:139-145
8. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 2002, 169:4712-4716
9. Meiron M, Zohar Y, Anunu R, Wildbaum G, Karin N: CXCL12 (SDF-1α) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells. J Exp Med 2008, 205: 2643-2655
10. + T cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 1997, 389:737-742
11. Wildbaum G, Netzer N, Karin N: Tr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading. J Clin Invest 2002, 110:701-710
12. Chen Y, Kuchroo VK, Inobe J, Hafler D, Weiner HL: Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994, 265:1237-1240 (Pubitemid 24291983)
13. Wildbaum G, Westermann J, Maor G, Karin N: A targeted DNA vaccine encoding Fas ligand defines its dual role in the regulation of experimental autoimmune encephalomyelitis. J Clin Invest 2000, 106:671-679
14. Pfeiffer C, Stein J, Southwood S, Ketelaar H, Sette A, Bottomly K: Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med 1995, 181:1569-1574
15. Refaeli Y, Van Parijs L, Alexander SI, Abbas AK: Interferon γ is required for activation-induced death of T lymphocytes. J Exp Med 2002, 196:999-1005
16. Tompkins SM, Padilla J, Dal Canto MC, Ting JP, Van Kaer L, Miller SD: De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J Immunol 2002, 168:4173-4183 (Pubitemid 34298426)
17. Schif-Zuck S, Westermann J, Netzer N, Zohar Y, Meiron M, Wildbaum G, Karin N: Targeted overexpression of IL-18 binding protein at the central nervous system overrides flexibility in functional polarization of antigen-specific Th2 cells. J Immunol 2005, 174:4307-4315 (Pubitemid 40396013)
18. Flugel A, Berkowicz T, Ritter T, Labeur M, Jenne DE, Li Z, Ellwart JW, Willem M, Lassmann H, Wekerle H: Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 2001, 14:547-560
19. + T lymphocytes: green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses. Nat Med 1999, 5:843-847
20. Fujita M, Otsuka T, Mizuno M, Tomi C, Yamamura T, Miyake S: Carcinoembryonic antigen-related cell adhesion molecule 1 modulates experimental autoimmune encephalomyelitis via an iNKT cell-dependent mechanism. Am J Pathol 2009, 175:1116-1123
21. Nashold FE, Spach KM, Spanier JA, Hayes CE: Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression. J Immunol 2009, 183:3672-3681
22. Yang J, Jiang Z, Fitzgerald DC, Ma C, Yu S, Li H, Zhao Z, Li Y, Ciric B, Curtis M, Rostami A, Zhang GX: Adult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis. J Clin Invest 2009, 119:3678-3691
23. Du C, Liu C, Kang J, Zhao G, Ye Z, Huang S, Li Z, Wu Z, Pei G: MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 2009, 10:1252-1259
24. Waldner H, Sobel RA, Howard E, Kuchroo VK: Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J Immunol 1997, 159:3100-3103 (Pubitemid 127482064)
25. Sabelko-Downes KA, Cross AH, Russell JH: Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis. J Exp Med 1999, 189:1195-1205
26. Suvannavejh GC, Dal Canto MC, Matis LA, Miller SD: Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis. J Clin Invest 2000, 105:223-231 (Pubitemid 30054362)
27. Steinman L: A rush to judgment on Th17. J Exp Med 2008, 205: 1517-1522
28. Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y, Bowman EP, Sgambellone NM, Chan CC, Caspi RR: Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 2008, 205:799-810
29. Tesmer LA, Lundy SK, Sarkar S, Fox DA: Th17 cells in human disease. Immunol Rev 2008, 223:87-113
30. Yu JJ, Ruddy MJ, Conti HR, Boonanantanasarn K, Gaffen SL: The interleukin-17 receptor plays a gender-dependent role in host protection against Porphyromonas gingivalis-induced periodontal bone loss. Infect Immun 2008, 76:4206-4213
31. Matsuzaki G, Umemura M: Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol 2007, 51:1139-1147
32. Carbonetti NH: Immunomodulation in the pathogenesis of Bordetella pertussis infection and disease. Curr Opin Pharmacol 2007, 7:272-278
33. Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L, Schluns K, Tian Q, Watowich SS, Jetten AM, Dong C: Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007, 448:480-483
34. + suppressor T cells: more questions than answers. Nat Rev Immunol 2002, 2:389-400
35. Lukacs NW, Strieter RM, Elner VM, Evanoff HL, Burdick M, Kunkel SL: Intercellular adhesion molecule-1 mediates the expression of monocyte-derived MIP-1α during monocyte-endothelial cell interactions. Blood 1994, 83:1174-1178 (Pubitemid 24978039)
36. O'Connor RA, Prendergast CT, Sabatos CA, Lau CW, Leech MD, Wraith DC, Anderton SM: Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 2008, 181:3750-3754
37. Tarrant TK, Silver PB, Wahlsten JL, Rizzo LV, Chan CC, Wiggert B, Caspi RR: Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon γ, nitric oxide, and apoptosis. J Exp Med 1999, 189:219-230
38. Ivanov II, Zhou L, Littman DR: Transcriptional regulation of Th17 cell differentiation. Semin Immunol 2007, 19:409-417